References
- Acar J, Goldstein F. Trends in bacterial resistance to fluoroquinolones. Clin Infect Dis 1997; 24: S67–73
- Schmitz F-J, Fluit A, Brisse S, Verhoef J, Koher K, Milatovic D. Molecular epidemiology of quinolone resistance and comparative in vitro activities of new quinolones against European Staphylococcus aureus isolates. FEMS Immunol Med Microbiol 1999; 26: 281–7
- Zhao X, Xu C, Domagala J, Drlica K. DNA topoisomerase targets of the fluoroquinolones: a strategy for avoiding bacterial resistance. Proc Natl Acad Sci USA 1997; 94: 13991–6
- Dong Y, Xu C, Zhao X, Domagala J, Drlica K. Fluoroquinolone action against mycobacteria: effects of C8 substituents on bacterial growth, survival, and resistance. Antimicrob Agents Chemother 1998; 42: 2978–84
- Dong Y, Zhao X, Domagala J, Drlica K. Effect of fluoroquinolone concentration on selection of resistant mutants of Mycobacterium bovis BCG and. Staphylococcus aureus. Antimicrob Agents Chemother 1999; 43: 1756–8
- Sindelar G, Zhao X, Liew A, Dong Y, Zhou J, Domagala J. Mutant prevention concentration (MFC) as a measure of fluoroquinolone potency against mycobacteria. Antimicrob Agents Chemother, (in press)
- Dong Y, Zhao X, Kreiswirth B, Drlica K. Mutant prevention concentration as a measure of antibiotic potency: studies with clinical isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother 2000; 44: 2581–4
- Blondeau J, Zhao X, Hansen G, Drlica K. Mutant prevention concentration (MFC) for fluoroquinolones with clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother, (in press)
- Zhao X, Drlica K. Restricting the selection of antibiotic-resistant mutants: a general strategy derived from fluoroquinolone studies. Clin Infect Dis, (in press)
- Zhou J-F, Dong Y, Zhao X, Lee S, Amin A, Ramaswamy S. Selection of antibiotic resistance: allelic diversity among fluoroquinolone-resistant mutations. J Inf Dis 2000; 182: 517–25
- Zhao X, Wang J-Y, Xu C, Dong Y, Zhou J, Domagala J. Killing of Staphylococcus aureus by C-8-methoxy fluoroquinolones. Antimicrob Agents Chemother 1998; 42: 956–8
- Chen D K, McGeer A, DeAzavedo J C, Low DE. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. N Engl J Med 1999; 341: 233–9